Diagnosis of pulmonary lymphoma with BALF using molecular biological technique.

Diagnosis of pulmonary lymphoma with BALF using molecular biological technique. - Diagnosis of pulmonary lymphoma with BALF.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021830

Enrollment

100

Registered

2016-04-07

Start date

2015-08-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Suspiscious of pulmonary lymphoma, and showing pulmonary infiltration in radiological examination, and will be recieved BAL for diagnosis. 2. Patients who are obtained with the prior written informed consent.

Exclusion criteria

Exclusion criteria: 1. Cases who are judged unsuitableness by attending doctors. 2. Cases who can not be recieved bronchoscopic examination in safety.

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity of an assessment of BALF with molecular biological technique for pulmonary lymphoma.	—

Countries

Japan

Contacts

Public ContactTakashi Kido

University of Occupational and Environmental Health, Japan Department of Respiratory Medicine

t-kido@med.uoeh-u.ac.jp0936917453

Outcome results